Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 3:11 pm Purchase | 13G | Rapport Therapeutics Inc. RAPP | Cormorant Asset Management LP | 2,940,921 8.040% | 638 (+0.02%) | View |
| 2024-11-14 3:10 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | Cormorant Asset Management LP | 2,790,462 8.100% | 648,956 (+30.30%) | View |
| 2024-11-14 3:10 pm Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | Cormorant Asset Management LP | 8,325,000 12.200% | 2,286,765 (+37.87%) | View |
| 2024-11-14 3:09 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management LP | 2,375,000 19.500% | 350,000 (+17.28%) | View |
| 2024-11-14 3:08 pm Purchase | 13G | Praxis Precision Medicines Inc. PRAX | Cormorant Asset Management LP | 1,140,000 4.670% | 506,655 (+80.00%) | View |
| 2024-11-14 3:06 pm Sale | 13G | VENTYX BIOSCIENCES INC VTYX | Cormorant Asset Management LP | 0 0.000% | -3,670,000 (Position Closed) | View |
| 2024-11-14 3:05 pm Sale | 13G | TSCAN THERAPEUTICS INC TCRX | Cormorant Asset Management LP | 0 0.000% | -2,500,000 (Position Closed) | View |
| 2024-11-14 3:05 pm Sale | 13G | Tarsus Pharmaceuticals Inc. TARS | Cormorant Asset Management LP | 500,000 1.310% | -1,721,422 (-77.49%) | View |
| 2024-11-14 3:05 pm Sale | 13G | NEUROGENE INC NGNE | Cormorant Asset Management LP | 107,344 0.830% | -638,836 (-85.61%) | View |
| 2024-11-14 3:04 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Cormorant Asset Management LP | 0 0.000% | -3,250,000 (Position Closed) | View |
| 2024-11-14 3:04 pm Sale | 13G | Korro Bio Inc. KRRO | Cormorant Asset Management LP | 265,826 2.860% | -263,344 (-49.77%) | View |
| 2024-11-14 3:03 pm Sale | 13G | IMMUNEERING CORP IMRX | Cormorant Asset Management LP | 0 0.000% | -1,700,000 (Position Closed) | View |
| 2024-11-14 3:03 pm Sale | 13G | CYTOMX THERAPEUTICS INC CTMX | Cormorant Asset Management LP | 0 0.000% | -5,750,000 (Position Closed) | View |
| 2024-11-14 3:02 pm Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | Cormorant Asset Management LP | 0 0.000% | -3,142,079 (Position Closed) | View |
| 2024-11-06 4:06 pm Purchase | 13G | BRIGHT MINDS BIOSCIENCES INC. DRUG | Cormorant Asset Management LP | 1,059,331 17.260% | 184,331 (+21.07%) | View |
| 2024-10-22 4:03 pm Purchase | 13G | BRIGHT MINDS BIOSCIENCES INC. DRUG | Cormorant Asset Management LP | 875,000 18.790% | 875,000 (New Position) | View |
| 2024-10-16 4:30 pm Sale | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Cormorant Asset Management LP | 1,837,739 14.520% | -57,978 (-3.06%) | View |
| 2024-10-11 4:22 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Cormorant Asset Management LP | 1,895,717 14.980% | 1,895,717 (New Position) | View |
| 2024-06-20 4:01 pm Purchase | 13G | Rapport Therapeutics Inc. RAPP | Cormorant Asset Management LP | 2,940,283 8.040% | 2,940,283 (New Position) | View |
| 2024-05-13 4:00 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | Cormorant Asset Management LP | 5,750,000 7.380% | 5,750,000 (New Position) | View |